Uncovering Institutional Buying In GT Biopharma Inc (NASDAQ: GTBP)
Currently, there are 2.23M common shares owned by the public and among those 1.96M shares have been available to trade. The company’s stock has a 5-day price change of 11.95% and 40.50% over the past three months. GTBP shares are trading -63.27% year to date (YTD), with the 12-month market performance down to -64.26% lower. […]
